Search research articles
Contact Us
Filters
Showing results (121-130 of 124) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 124 results.
Journal of Neuroengineering and Rehabilitation
|
January 8, 2026
Leveraging neural drive to assess hand motor function in individuals with chronic stroke
Nicholas Tacca, Jackson T Levine, Mary K Heimann, et al.
Frontiers in Child and Adolescent Psychiatry
|
April 2, 2025
Multisystemic resilience and its impact on youth mental health: reflections on co-designing a multi-disciplinary, participatory study
Linda Theron, Matteo Bergamini, Cassey Chambers, et al.
Development (Cambridge, England)
|
September 28, 2019
EvoChromo: towards a synthesis of chromatin biology and evolution
Ines A Drinnenberg, Frédéric Berger, Simon J Elsässer, et al.
Nature Aging
|
February 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease
M H Werner, A McGarry, C Meyer, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 124) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 124 results.
Journal of Neuroengineering and Rehabilitation
|
January 8, 2026
Leveraging neural drive to assess hand motor function in individuals with chronic stroke
Nicholas Tacca, Jackson T Levine, Mary K Heimann, et al.
Frontiers in Child and Adolescent Psychiatry
|
April 2, 2025
Multisystemic resilience and its impact on youth mental health: reflections on co-designing a multi-disciplinary, participatory study
Linda Theron, Matteo Bergamini, Cassey Chambers, et al.
Development (Cambridge, England)
|
September 28, 2019
EvoChromo: towards a synthesis of chromatin biology and evolution
Ines A Drinnenberg, Frédéric Berger, Simon J Elsässer, et al.
Nature Aging
|
February 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease
M H Werner, A McGarry, C Meyer, et al.
Page
of 13